These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 524179)
21. [D-penicillamine in the treatment of patients with rheumatoid arthritis]. Gracheva GV; Erov NK; Romanovskaia LR Ter Arkh; 1983; 55(9):94-8. PubMed ID: 6605592 [No Abstract] [Full Text] [Related]
22. [Results of Cuprenil (D-penicillamine) treatment in patients with rheumatoid arthritis]. Maldykowa H; Chwalińska-Sadowska H; Luft S; Glińska-Urban D; Mikolajew M; Odrzywolska A; Jaworska H Reumatologia; 1972; 10(1):9-21. PubMed ID: 5019762 [No Abstract] [Full Text] [Related]
23. [Our experience in the treatment of rheumatoid arthritis with D-penicillamine]. Wysocka K; Kiczak J; Hawrylak E Wiad Lek; 1980 Apr; 33(8):607-10. PubMed ID: 7405223 [No Abstract] [Full Text] [Related]
25. [Current aspects of D-penicillamine and pregnancy]. Miehle W Z Rheumatol; 1988; 47 Suppl 1():20-3. PubMed ID: 3063004 [TBL] [Abstract][Full Text] [Related]
26. [Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis]. Brenner S; Caspi D; Tchetchik R; Krakowski A; Yaron M Harefuah; 1983 Feb; 104(3):94-6. PubMed ID: 6618302 [No Abstract] [Full Text] [Related]
27. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis]. Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994 [No Abstract] [Full Text] [Related]
28. [The failures of D penicillamine]. Ayrolles C; Guyard C; Fournié A Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):161-4. PubMed ID: 653292 [TBL] [Abstract][Full Text] [Related]
29. [3 cases of obliterating bronchiolitis during treatment of rheumatoid polyarthritis with D-penicillamine]. Renier JC; Bontoux-Carre E; Racineux JL Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):25-6. PubMed ID: 3704508 [TBL] [Abstract][Full Text] [Related]
30. [Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis]. Ongerboer de Visser BW; van Soesbergen RM Ned Tijdschr Geneeskd; 1978 Dec; 122(52):2055-8. PubMed ID: 732905 [No Abstract] [Full Text] [Related]
31. Stimulation single fiber EMG study in patients receiving a long-term D-penicillamine treatment for rheumatoid arthritis. Dominkus M; Grisold W; Albrecht G Muscle Nerve; 1992 Nov; 15(11):1300-1. PubMed ID: 1488070 [No Abstract] [Full Text] [Related]
32. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy. Munthe E; Kåss E J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435 [TBL] [Abstract][Full Text] [Related]
33. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)]. Warnatz H; Scheiffarth F; Gutmann W Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648 [TBL] [Abstract][Full Text] [Related]
34. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)]. Waskönig FW; Meyer W Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138 [No Abstract] [Full Text] [Related]
35. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis. Wysocka K; Fabian F; Listewnik M Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112 [TBL] [Abstract][Full Text] [Related]
36. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study. Weinstein A; Rothfield NF J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646 [TBL] [Abstract][Full Text] [Related]